NCT00493727View on ClinicalTrials.gov

Use of Mucomyst to Ameliorate Oxidant Stress in Diabetics With Proteinuria

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
DiabetesProteinuria
Interventions
DRUG

N-acetylcysteine(Mucomyst)

Trial Locations (1)

45428

VA Medical Center, Dayton, Dayton

All Listed Sponsors
collaborator

West Virginia University

OTHER

lead

US Department of Veterans Affairs

FED

NCT00493727 - Use of Mucomyst to Ameliorate Oxidant Stress in Diabetics With Proteinuria | Biotech Hunter | Biotech Hunter